Loading......
Fmoc-N-amido-PEG1-acetic acid is a PEG-based spacer and synthetic linker building block used to introduce a defined hydrophilic and flexible segment into multistep conjugation designs. The PEG chain can increase molecular spacing and provide a modular connection between reactive groups without serving as a dedicated cleavage trigger. This derivative contains peg1 spacer together with terminal functionality selected for further synthesis. The available reactive group is no dedicated antibody-reactive group unless activated/functionalized; terminal functionality depends on the specific peg derivative. The opposite terminus provides terminal carboxylic acid; activate for coupling to an amine-bearing payload. Coupling and deprotection conditions should be matched to the terminal groups and the intended order of assembly.
Structure of 260367-12-2
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Fmoc-N-amido-PEG1-acetic acid, a versatile chemical linker, finds wide utilization in biochemical and pharmaceutical research. Below are four key applications of this compound:
Peptide Synthesis: Integral to solid-phase peptide synthesis, Fmoc-N-amido-PEG1-acetic acid plays a crucial role in constructing peptides. The Fmoc group shields the terminal amino group throughout the synthesis process, enabling the sequential addition of amino acids. This method offers researchers a dependable approach to creating intricate peptides with elevated yields and purity levels.
Drug Delivery: This compound serves as a cornerstone in designing drug delivery systems that leverage PEG to enhance drug solubility, stability, and biocompatibility. By conjugating drugs to Fmoc-N-amido-PEG1-acetic acid, researchers can enhance the pharmacokinetic properties of the resulting compounds. This augmentation not only boosts therapeutic efficacy but also mitigates the adverse effects associated with drug treatments.
Surface Modification: Employing Fmoc-N-amido-PEG1-acetic acid enhances the biocompatibility and functionality of nanoparticle surfaces, biomaterials, and medical devices. The PEG component forms a hydrophilic layer that reduces protein adsorption and cellular interactions, crucial for applications spanning biosensors to implantable devices. This modification guarantees the stability and optimal performance of these devices within biological settings.
Protein Engineering: In the realm of protein engineering, Fmoc-N-amido-PEG1-acetic acid enables site-specific PEGylation of proteins, enhancing their pharmacokinetic characteristics. By attaching PEG chains to precise residues, researchers can prolong the circulation time of therapeutic proteins in the bloodstream while lowering their immunogenicity. This transformation renders the proteins more suitable for diverse therapeutic applications, promising advancements in the realm of medical treatments.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
Loading......